Table 2.
Clinical actions taken during each interval
| Clinical Action, % (n) | Baseline | Intervention I | Intervention II |
|---|---|---|---|
| (n=123) | (n=109) | (n=76) | |
| Repeat Cr | 81 (99) | 83 (90) | 83 (63) |
| Follow up Cr at 0–7 days | 35 (61) | 42 (66) | 28 (29) |
| Follow up Cr at 8–89 days | 79 (139) | 71 (113) | 70 (73) |
| Follow up Cr at 90–120 days | 30 (87) | 41 (65) | 36 (38) |
| Encourage hydration | 42 (51) | 48 (52) | 49 (37) |
| Discontinuation of nephrotoxins | 18 (22) | 19 (21) | 38 (29) |
| Change dosing | 35 (43) | 36 (39) | 25 (19) |
| Nephrology consult | 7 (9) | 2 (2) | 0 (0) |
| Hospitalization | 15 (18) | 12 (13) | 15 (11) |
Cr, creatinine.